First Time Loading...

Tibet Aim Pharm Inc
SZSE:002826

Watchlist Manager
Tibet Aim Pharm Inc Logo
Tibet Aim Pharm Inc
SZSE:002826
Watchlist
Price: 9.19 CNY 3.14% Market Closed
Updated: May 6, 2024

Wall Street
Price Targets

Price Targets Summary
Tibet Aim Pharm Inc

Wall Street analysts forecast Tibet Aim Pharm Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tibet Aim Pharm Inc is 12 CNY .

Lowest
Price Target
Not Available
Average
Price Target
12 CNY
31% Upside
Highest
Price Target
Not Available
Tibet Aim Pharm Inc Competitors:
Price Targets
603998
Hunan Fangsheng Pharmaceutical Co Ltd
14% Downside
ROG
Roche Holding AG
28% Upside
PAHC
Phibro Animal Health Corp
36% Downside
COPN
Cosmo Pharmaceuticals NV
26% Upside
PLTH
Planet 13 Holdings Inc
181% Upside
CAMX
Camurus AB
19% Upside
003850
Boryung Corp
57% Upside
600594
Guizhou Yibai Pharmaceutical Co Ltd
54% Upside

Revenue
Forecast

Revenue Estimate
Tibet Aim Pharm Inc

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's revenue is 14%. The projected CAGR for the next 6 years is -11%.

14%
Past Growth
-11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tibet Aim Pharm Inc

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's operating income is 7%. The projected CAGR for the next 6 years is 1%.

7%
Past Growth
1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Tibet Aim Pharm Inc

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's net income is 4%. The projected CAGR for the next 6 years is 6%.

4%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tibet Aim Pharm Inc's stock price target?
Price Target
12 CNY

According to Wall Street analysts, the average 1-year price target for Tibet Aim Pharm Inc is 12 CNY .

What is Tibet Aim Pharm Inc's Revenue forecast?
Projected CAGR
-11%

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's revenue is 14%. The projected CAGR for the next 6 years is -11%.

What is Tibet Aim Pharm Inc's Operating Income forecast?
Projected CAGR
1%

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's operating income is 7%. The projected CAGR for the next 6 years is 1%.

What is Tibet Aim Pharm Inc's Net Income forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's net income is 4%. The projected CAGR for the next 6 years is 6%.